about
Physiological and Pharmacological Roles of FGF21 in Cardiovascular DiseasesAerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAsObesity and hypertensive heart disease: focus on body composition and sex differencesCardiac Imaging in Heart Failure with Comorbidities.MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant HypertensionAssociation of CKIP-1 P21A polymorphism with risk of chronic heart failure in a Chinese population.SIRT1 functions as an important regulator of estrogen-mediated cardiomyocyte protection in angiotensin II-induced heart hypertrophy.Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction.Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy.A peptide of the RGS domain of GRK2 binds and inhibits Gα(q) to suppress pathological cardiac hypertrophy and dysfunction.Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study.Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats.Effect of increased left ventricle mass on ischemia assessment in electrocardiographic signals: rabbit isolated heart study.Mitochondrial Function in Engineered Cardiac Tissues is Co-Regulated by Extracellular Matrix Elasticity and Tissue Alignment.Melatonin, mitochondria and hypertension.Impaired ADP channeling to mitochondria and elevated reactive oxygen species in hypertensive hearts.Prognostic Application of Thoracic Aortic Calcium Scoring for Adverse Clinical Outcome Risk in Elderly Patients with Left Ventricular Hypertrophy.Impact of echocardiography on one-month and one-year mortality of intertrochanteric fracture patients.VCP represses pathological cardiac hypertrophy.Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.Regression of Left Ventricular Mass After Bariatric Surgery.Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.Cardiomyocyte loss is not required for the progression of left ventricular hypertrophy induced by pressure overload in female mice.The CD147/MMP-2 signaling pathway may regulate early stage cardiac remodelling in spontaneously hypertensive rats.MicroRNAs Mediate Beneficial Effects of Exercise in Heart.Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy.Disease Modifiers of Inherited Channelopathy
P2860
Q26744232-A1EB7383-5DD7-4D15-8DEA-A24B23171EEDQ26827482-371C9B5A-06B9-44BE-9F66-8C8D5A90A09FQ28073418-D1187A63-E77E-4CB0-A798-998C30B74F75Q30248624-E948F489-B217-4E11-BDDD-6048BFAF4D9DQ33647436-62909A76-148E-44F5-95A9-54B0582EB75FQ33829555-2EA31DDE-61BD-42D7-B024-C9B2A6D7DC5AQ34966315-6C045D11-2CAD-4386-A049-332DE37F8C8DQ35003747-E8BCAFA7-B3E2-40D3-854B-A71E1A20FBA8Q36476890-9F707816-02F7-41C8-9D56-A02FFE5D5F38Q37206993-2F9F65AC-871E-48E0-8B7C-6E22655E62FAQ37241927-66A38FD0-02F3-40CA-A2A8-4F9302FDC33AQ37299336-266FA041-C5D4-4416-B5F3-6E98319BBDEAQ37661093-14ADE0A9-19C7-4824-B572-F929BBE70EB4Q38640417-1ADC684E-88D7-4611-A9EB-16EFC748FB27Q38667230-85EC8298-D753-4126-B1EB-E5D179B30F46Q46323757-EE79B432-2B46-415D-B1D9-BD06DD8C8250Q46562871-ACAA80E3-E391-42FA-AB58-392734750F8AQ47110146-577F6328-5B52-471B-830B-468A44481500Q47179239-47AAA6CC-85F4-428A-B7EB-3A7DCCDB1C1EQ47249639-0152261C-7E92-4DF3-9D2D-D9ECE7577CBAQ47682969-432F7FEC-18B1-4E3F-A235-6F03D2081E44Q47703503-6AF1AE2F-E8EC-4089-9782-77B039ADC591Q48146412-E963E741-7409-48FC-8A44-01607423FFB9Q50918490-C499A7BA-84CF-4784-8E4B-8C9D0F3AAC52Q51620512-48092619-4F97-4A5B-A082-DEEA388B999BQ51787118-8AAC43EA-2E3C-4860-97B5-BC8235B956D9Q54276311-D012CBA1-7D61-4757-BF93-4FA326B8CBA7Q57486424-E7B54989-F1F8-4579-85C9-5F63A3AEAB64
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myocardial remodeling in hypertension.
@en
type
label
Myocardial remodeling in hypertension.
@en
prefLabel
Myocardial remodeling in hypertension.
@en
P2860
P356
P1476
Myocardial remodeling in hypertension.
@en
P2093
P2860
P2888
P356
10.1038/JHH.2014.36
P577
2014-05-08T00:00:00Z
P5875
P6179
1023994752